Citadel Advisors’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Buy |
49,441
+28,961
| +141% | +$77.6K | ﹤0.01% | 5161 |
|
|
2025
Q1 | $87.7K | Buy |
20,480
+8,201
| +67% | +$35.1K | ﹤0.01% | 5200 |
|
|
2024
Q4 | $49.1K | Sell |
12,279
-7,836
| -39% | -$31.3K | ﹤0.01% | 5457 |
|
|
2024
Q3 | $103K | Buy |
+20,115
| New | +$103K | ﹤0.01% | 4911 |
|
|
2024
Q1 | – | Sell |
-10,112
| Closed | -$92.3K | – | 6645 |
|
|
2023
Q4 | $92.3K | Sell |
10,112
-160,309
| -94% | -$1.46M | ﹤0.01% | 4901 |
|
|
2023
Q3 | $1.49M | Hold |
170,421
| – | – | ﹤0.01% | 2665 |
|
|
2023
Q2 | $1.19M | Hold |
170,421
| – | – | ﹤0.01% | 2816 |
|
|
2023
Q1 | $3.34M | Sell |
170,421
-37
| -0% | -$724 | ﹤0.01% | 2110 |
|
|
2022
Q4 | $1.7M | Sell |
170,458
-1,350
| -0.8% | -$13.5K | ﹤0.01% | 2709 |
|
|
2022
Q3 | $1.7M | Sell |
171,808
-79,160
| -32% | -$784K | ﹤0.01% | 2897 |
|
|
2022
Q2 | $2.5M | Sell |
250,968
-10,626
| -4% | -$106K | ﹤0.01% | 2524 |
|
|
2022
Q1 | $2.59M | Sell |
261,594
-1,687
| -0.6% | -$16.7K | ﹤0.01% | 2728 |
|
|
2021
Q4 | $2.63M | Buy |
263,281
+3,457
| +1% | +$34.6K | ﹤0.01% | 2746 |
|
|
2021
Q3 | $2.57M | Buy |
259,824
+4,385
| +2% | +$43.4K | ﹤0.01% | 2729 |
|
|
2021
Q2 | $2.61M | Sell |
255,439
-3,651
| -1% | -$37.2K | ﹤0.01% | 2912 |
|
|
2021
Q1 | $2.91M | Buy |
259,090
+9,090
| +4% | +$102K | ﹤0.01% | 2759 |
|
|
2020
Q4 | $3.2M | Hold |
250,000
| – | – | ﹤0.01% | 2150 |
|
|
2020
Q3 | $2.75M | Buy |
+250,000
| New | +$2.75M | ﹤0.01% | 1979 |
|